|
Market Closed -
Warsaw S.E.
19:55:50 25/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 210.50 PLN | +1.84% |
|
-0.96% | +34.29% |
| 08-25 | Bayer Group Receives Approval For Sevabertinib In Japan For HER2-Mutant Non-Small Cell Lung Cancer | CI |
| 08-24 | CAC 40 pauses ahead of Nvidia and Jackson Hole |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BAYER AG | Other Pharmaceuticals | +1.84% | -0.96% | - | - | - | 55.58B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BAYN Stock
- BAY Stock
- Charts Bayer AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
